REPROGRAM: REsilience PROmotion with GeRoprotectors: AssessMent of biological effect: Rationale and protocol for a trial of biological effect
Daisy Wilson, Animesh Acharjee, Niharika A Duggal, Jose R Hombrebueno, Simon W Jones, Jonathan W Lewis, João Pedro de Magalhães, Yessica Martinez-Serrato · 2026
Read REPROGRAM: REsilience PROmotion with GeRoprotectors: AssessMent of biological effect: Rationale and protocol for a trial of biological effect by Daisy Wilson, Animesh Acharjee, Niharika A Duggal, Jose R Hombrebueno, Simon W Jones, Jonathan W Lewis, João Pedro de Magalhães, Yessica Martinez-Serrato (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0346347.txt.
Description
Drugs that may slow aging itself, nicknamed geroprotectors, are the focus of the REPROGRAM trial described by Daisy Wilson and colleagues. This 2026 PLOS One paper is a protocol, setting out how sixty healthy adults aged seventy and over in England will test three such drugs over three weeks.
Volunteers will receive metformin, fisetin, or spermidine, with blood, fat, and stool samples taken before and after. The main question is whether the drugs cut the number of worn-out, senescent cells in fat tissue. The team will also track inflammation, cell cleanup systems, and gut microbes. No results are reported yet.
Catalog record
| CREATOR | Daisy Wilson, Animesh Acharjee, Niharika A Duggal, Jose R Hombrebueno, Simon W Jones, Jonathan W Lewis, João Pedro de Magalhães, Yessica Martinez-Serrato |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42893 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |